课题基金 / 基金详情

METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS

METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
代谢醛作为抗结核病的免疫效应物
批准号:
10028048
负责人:
Katerina Heran Darwin
金额:
$84.07万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31

项目摘要

项目成果

Katerina Heran Darwin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal will test the hypothesis that host-derived aldehydes are a critical component of host immunity against Mycobacterium tuberculosis. We will use bacterial and mouse genetics, biochemistry, immunology and cell biology experiments to test this hypothesis. We will identify bacterial mutants that are either more resistant or more sensitive than parental strains to various aldehydes in combination with nitric oxide, which appears to strongly synergize with several different aldehydes to kill bacteria. The isolation of these bacterial strains will allow us to test whether or not these pathways contribute to bacterial survival in mice. We will also investigate various host pathways from aerobic glycolysis to aldehyde dehydrogenase activity to assess the contribution of aldehyde products of these pathways in bacterial infection control. The outcome of our studies may ultimately help promote a clinical trial repurposing an FDA-approved drug for the treatment of tuberculosis and possibly other diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2022 Microbial Toxins and Pathogenicity Gordon Research Conference and Seminar
  • 批准号:
    10314283
  • 项目类别:
  • 资助金额:
    $1.3万
  • 财政年份:
    2021
  • 负责人:
    Katerina Heran Darwin
  • 依托单位:
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
海外基金